Heavy menstrual bleeding (HMB) is a common gynaecological problem affecting
around 20% of women of reproductive age. It has a major adverse effect on the physical,
mental wellbeing and quality of life of many women [1]. It also contributes considerably to
medical care costs in addition to its significant effect on quality of life and reproductivity of
sufferers [2].
Endometrial ablation (EA); introduced first in the late 19th century; a minimally invasive
gynaecologic tool to control profuse vaginal bleeding avoiding hysterectomy and it has
been widely used in the developed world filling the gap between medical therapy and
hysterectomy.
EA is a safe procedure, requires nominal training and enjoys a substantial rate of success
which has contributed to some extent to a significant reduction in hysterectomy rates in the
United States & the UK between the years 1998 and 2010 [3,4].
According to a recently published Cochrane review, no apparent differences between
1st and 2nd generation methods of EA were found in women with HMB including patient`s
satisfaction, inability to work, quality of life or requirement for further surgery [5].
The impedance bipolar radiofrequency ablation (Novasure) is a second-generation
non-resectoscopic technique which has been used since more than 15 years with over 2.5
million women treated. It is quick and Simple with no pre-treatment
required, performed at any time during the menstrual cycle and can
be learnt easily with less complications and shorter operation time .
It utilises unique patented technology to deliver customised ablation
to each patient [6]. It has a favourable safety profile with patient
satisfaction rate reaching 90% and amenorrhoea rate at 12 months
acceding 55% [7].
Late Onset Endometrial Ablation Failure (LOEAF) has been
previously published to indicate that about a quarter of women who
undergo the procedure will eventually require a hysterectomy while
an unknown number have less than satisfactory results [8]. The
author recommended understanding the etiology and risk factors
that predispose to LOEAF. Different reasons leading to LOEAF were
reported excluding uterine scar (s) as a possible leading cause for
LOEAF [8]. There is only scarce data indicating the influence of having
a scarred uterus on the outcome of EA [9,10]. There are no previous
data comparing the outcome of Novasure ablation in women with
scarred and unscarred uterus, hence this study was conducted.